NFJQWTOAVBZCBF-ZCRGAIPPSA-N
Compound with spectra: 1 NMR
| SpectraBase Compound ID | GETitNQ7z3H |
|---|---|
| InChI | InChI=1S/C15H24O2/c1-9(2)13-8-14-11(4)5-6-12(14)10(3)7-15(13,16)17-14/h10-12,16H,5-8H2,1-4H3/t10-,11-,12-,14-,15+/m0/s1 |
| InChIKey | NFJQWTOAVBZCBF-ZCRGAIPPSA-N |
| Mol Weight | 236.35 g/mol |
| Molecular Formula | C15H24O2 |
| Exact Mass | 236.17763 g/mol |
| Enantiomer InChIKey | NFJQWTOAVBZCBF-FWZIUSJTSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
(2-beta,3a-alpha,3b-beta,6a-beta,7a-alpha)-2-Acetoxy-decahydro-3a-hydroxy-4,4,6a-trimethyl-3-methylidene-3aH-cyclopenta[a]pentalene
7-ALPHA,8-ALPHA-DIHYDROXYLABDA-13(16),14-DIEN-19-YL-CIS-4-HYDROXYCINNAMATE
(5R,7S,9R,10S)-7-Hydroxy-7,12-epidioxycadinan-3,6(11)-dien-2-one
(+)-(5-R,7-S,9-R,10-S)-7-HYDROXY-7,12-EPIDIOXYCADINAN-3,6-(11)-DIEN-2-ONE
19-Acetoxy-5(R),15,16-trihydroxyspata-13,17(Z)-diene
1.beta.,4.beta.,4.alpha.,5.beta.-Diepoxy-10.alpha.,11.alpha.H-xantha-12,8.beta.-olide
KUHISTANICAOL-E
(3aS,6R,6aS,9S,10aS)-2,3,6,9-tetramethyl-3a,4,5,6,6a,7,8,10-octahydrobenzo[h]benzofuran-9-ol
#9;(1R,2R,4AS,8AS,3'R,4'E,1''S)-(+)-1-[6'-(2'',2''-DIMETHYL-6''-METHYLENECYCLOHEXYL)-4'-METHYLHEX-4'-ENYL]-2,3'-EPOXY-2,5,5,8A-TETRAMETHYLDECAHYDRONAPHTHALEN-2-OL
Spiro[2H-indene-2,2'-pyrrolidin]-1-ol, 1,3-dihydro-5,6-dimethoxy-1'-(phenylmethyl)-, trans-
| Title | Journal or Book | Year |
|---|---|---|
| Medicinal Foodstuffs. XXVIII. Inhibitors of Nitric Oxide Production and New Sesquiterpenes, Zedoarofuran, 4-Epicurcumenol, Neocurcumenol, Gajutsulactones A and B, and Zedoarolides A and B, from Zedoariae Rhizoma. | Chemical and Pharmaceutical Bulletin | 2001 |
This compound is available in the following databases:
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.